Objective Disease activity both between and within patients with SLE is highly variable, yet factors driving this variability remain unclear. This study aimed to identify predictors of variability in ...
Evaluation of primary aldosteronism testing in hypertensive patients with SLE in a tertiary hospital
S L E is a chronic multisystem autoimmune disease in which cardiovascular disease is a leading cause of mortality, with a ...
Background SLE is a systemic autoimmune disease with a large number of common risk gene variants, but several rare gene ...
No HTML tags allowed. Web page addresses and e-mail addresses turn into links automatically. Lines and paragraphs break automatically.
Low versus high initial oral glucocorticoid dose for lupus nephritis: a pooled analysis of randomised controlled clinical trials (6 January, 2025) ...
Background Neuropsychiatric symptoms are highly prevalent among systemic lupus erythematosus (SLE) patients, being clinically observed in up to 80% of adult and 95% of pediatric patients. Type 1 ...
The Lupus Foundation of America is a charitable organization with tax-exempt status granted under Section 501(c)(3) of the Internal Revenue Code. The LFA’s Federal ID# is 43-1131436. Donations are tax ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback